| 代表性成果 (论文/专利/专著等) | 1.         Zhihua Liu*; Yahui Zhao; Pengzhou Kong; Yuhao   Liu; Jing Huang; Enwei Xu; Wenqing Wei; Guangyu Li; Xiaolong Cheng; Liyan   Xue; Yi Li; Hongyan Chen; Shuqing Wei; Ruifang Sun; Heyang Cui; Yongsheng   Meng; Meilin Liu; Yang Li; Riyue Feng; Xiao Yu; Rui Zhu; Yenan Wu; Lei Li;   Bin Yang; Yanchun Ma; Jiawei Wang; Wenjie Zhu; Dongjie Deng; Yanfeng Xi; Fang   Wang; Hongyi Li; Shiping Guo; Xiaofei Zhuang; Xiaoyue Wang; Yuchen Jiao*; Yongping   Cui*; Qimin Zhan* , Integrated Multi-omics Profiling Yields a   Clinically-Relevant Molecular Classification for Esophageal Squamous Cell   Carcinoma, Cancer Cell, 2023 Jan 9,41, 1-15. IF=38.585 2.         Heyang Cui#, Yong Zhou#, Fang Wang#, Caixia   Cheng#, Weimin Zhang#, Ruifang Sun#, Ling Zhang#, Yanghui Bi, Min Guo, Yan   Zhou, Xinhui Wang, Jiaxin Ren, Ruibing Bai, Ning Ding, Chen Cheng, Longlong   Wang, Xuehan Zhuang, Mingwei Gao, Yongjia Weng, Yueguang Wu, Huijuan Liu,   Shuaicheng Li, Shubin Wang, Xiaolong Cheng, Yongping Cui*, Zhihua Liu*&   Qimin   Zhan*.Characterization of Somatic Structural Variations in   528 Chinese individuals with Esophageal Squamous Cell Carcinoma.Nature   Communications.2022 Oct 22;13(1):6296. doi: 10.1038/s41467-022-33994-3. IF=17.694 3.         Li Y#, Yang B, Ma Y, Peng X, Wang Z, Sheng   B, Wei Z, Cui Y*, Liu Z*. Phosphoproteomics reveals therapeutic targets of   esophageal squamous cell carcinoma. Signal Transduct Target Ther. 2021 Nov   12;6(1):381. doi: 10.1038/s41392-021-00682-5.  IF=38.104 4.         Yongping Cui#, Hongyan Chen#, Ruibin Xi#, Heyang   Cui#, Yahui Zhao#, Enwei   Xu#, Ting Yan, Xiaomei Lu, Furong Huang, Pengzhou Kong, Yang Li, Xiaolin Zhu,   Jiawei Wang, Wenjie Zhu, Jie Wang, Yanchun Ma, Yong Zhou, Shiping Guo,Ling   Zhang, Yiqian Liu, Bin Wang, Yanfeng Xi, Ruifang Sun, Xiao Yu, Yuanfang Zhai,   Fang Wang, Jian Yang, Bin Yang, Caixia Cheng, Jing Liu, Bin Song, Hongyi Li,   Yi Wang, Yingchun Zhang, Xiaolong Cheng, Qimin Zhan*, Yanhong Li*, Zhihua   Liu*. Whole-genome Sequencing of 508 Patients Identifies Key Molecular   Features Associated With Poor Prognosis in Esophageal Squamous Cell   Carcinoma. Cell Res. 2020, 30(10):902-913. doi: 10.1038/s41422-020-0333-6. IF=46.297 5.         Zhang, Z.#, Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C.. Overcoming cancer therapeutic   bottleneck by drug repurposing. Signal Transduction and Targeted Therapy,   5(1).(2020).doi:10.1038/s41392-020-00213-8  IF=38.104 |